Skip to main content

Table 2 Trial schedule

From: Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol

Protocol treatments and assessments

Pre-enrollment

Week 1

Week 4

Week8

Week 12

Week 16

Week 20

Week 24

Mastectomy

Protocol treatments

Letrozole

 

Zoledronic acid

 

      

Demographics, current medications, dental examination

        

Physical examination

 

1

      

Complete blood count, blood biochemical test, bone metabolism markers

 

2

 

 

 

Enhanced MRI, tumor markers

   

  

 

Palpation, ultrasound examination

 

 

Vδ1+ T cells and Vδ2+ T cells in peripheral blood 3

  

   

 

IFN- γ 4

  

      

Pathological examination5

  

    

PEPI score

        

  1. 1Body temperature before and 4–6 hours after the administration of zoledronic acid.
  2. 2Bone metabolism markers that are expected.
  3. 3The frequency of Vδ1+ T cells and Vδ2+ T cells among CD3+ T cells in peripheral blood.
  4. 4IFN-γ at 4–6 hours after the administration of zoledronic acid.
  5. 5ER, PgR, Ki67.